An osteoporosis diagnosis can leave patients with many questions: What does my DEXA scan mean? Which treatment is right for me? Am I getting enough calcium and protein? And what type of exercise can help improve my bone health?

In this episode of MedInsights Unleashed, Dr Tomasz (Tom) Forfa, BCom/BSci, MBBS, returns to discuss the PREFER study, exploring how patient preferences may influence treatment satisfaction and the likelihood of staying on therapy. Drawing on his medical background and personal experience with osteoporosis, Tom introduces Lenari – Osteoporosis Guide, a patient-focused app designed to help people understand their diagnosis and DEXA results, explore treatment options, assess nutrition and supplementation, and prepare for more informed discussions with their healthcare providers.

Lenari – Osteoporosis Guide is available on the Apple App Store and Google Play.

What happens when a family calls 911 for someone receiving hospice care? During an already emotional moment, families and first responders may suddenly face difficult questions about treatment, transportation, resuscitation and the patient’s wishes.

In this episode of MedInsights Unleashed, Devin Hinchcliffe, Police Officer, EMT, PHTLS, returns to discuss what families should know before an end-of-life emergency occurs. We explore hospice versus palliative care, what happens when EMS is called, the importance of goals of care, and why documents such as DNRs, POLST/MOLST forms and advance directives need to be completed, understood and readily accessible before a crisis.

Advanced cancer diagnostics can provide increasingly sophisticated information about tumor biology, but developing the test is only part of the challenge. How do we make these technologies available to patients wherever they receive care?

In this episode of MedInsights Unleashed, Dr. Oliver F. Bathe, MD, MSc, FRCSC, FACS, Professor of Surgery and Oncology at the University of Calgary and Founder and CEO of Qualisure Diagnostics, discusses the challenges of centralized testing and the move toward more decentralized approaches. He explores RNA and transcriptomics, computational assays, and the potential role of AI in helping make advanced cancer diagnostics more reproducible, scalable and accessible to patients.

Qualisure Diagnostics Inc contact information:

Oliver F. Bathe, MD - CEO & Founder

3655 36th Street NW Calgary, Alberta T2L 1Y8

p: +1 403.614.7124

e: obathe@qualisuredx.com | www.qualisuredx.com